Growth Investor with GrowthCap‘s RJ Lumba
Business:Investing
Eliot Forster is the Chief Executive Officer of F-star Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer. To date, the company has built a comprehensive IP estate, with over 200 issued patents and more than 60 pending applications, many of which have blockbuster potential.
In this conversation, we discuss Eliot’s career as a corporate executive in big pharma as well as his transition to and leadership experience in venture and growth stage biotech. Before coming to F-star in 2018, he served as chief executive officer of Immunocore and prior to that, he held executive positions at Creabilis Therapeutics, Solace Pharmaceuticals, and Pfizer.
We also explore the broader biotech industry in the context of private company investing as well as the specifics of F-star’s drug development programs.
We hope you enjoy the show
Insight Venture Partners' Ryan Hinkle on Software Investing
KKR's Head of TMT Growth Equity Dave Welsh
Leading Innovation with Leo Rinaldi, Executive and Author
Growth Investor Vinay Kashyap of Mainsail Partners and His Focus on Bootstrapped Software Companies
Ken Kraemer, CEO of Deep Focus, Premier Advertising Agency for the World's Top Brands
Acclaimed Business Writer Bo Burlingham on Companies That Chose to Become Great Instead of Big
A Conversation with Media Tycoon and Investor Eric Hippeau
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast